Taltirelin tetrahydrate is a hydrate that is the tetrahydrate form of taltirelin. It activates neuronal cells by promoting the release and turnover of neurotransmitters (acetylcholine, dopamine) and its nerve growth factor-like action. The drug is approved in Japan and used to treat ataxia (daily activities including gait, eating, and conversation) in patients suffering from spinocerebellar degeneration. Among its listed roles, it functions as a central nervous system drug. It includes a taltirelin. The directory classifies it as a commercial API with a peptide source/manufacturing origin. Other names for this substance include Taltirelin hydrate and Ceredist. Its PubChem CID is 656609.
Taltirelin tetrahydrate
| CAS No | 201677-75-0 |
|---|---|
| Molecular Formula | C17H31N7O9 |
| Molecular Weight | 477.5 g/mol |
| Synonyms | (4S)-N-[(2S)-1-[(2S)-2-carbamoylpyrrolidin-1-yl]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-1-methyl-2,6-dioxo-1,3-diazinane-4-carboxamide;tetrahydrate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Taltirelin tetrahydrate is a hydrate that is the tetrahydrate form of taltirelin. It activates neuronal cells by promoting the release and turnover of neurotransmitters (acetylcholine, dopamine) and its nerve growth factor-like action.
The listed CAS number is 201677-75-0.
The listed molecular formula is C17H31N7O9.
The listed molecular weight is 477.5 g/mol.
(4S)-N-[(2S)-1-[(2S)-2-carbamoylpyrrolidin-1-yl]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-1-methyl-2,6-dioxo-1,3-diazinane-4-carboxamide;tetrahydrate.
The source lists Taltirelin hydrate and Ceredist.